Skip to content

Medical-device intelligence

MKT: Hepatitis Viral B Dna Detection

FDA product code MKT: Hepatitis Viral B Dna Detection. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MKT
FDA device name
Hepatitis Viral B Dna Detection
Device class
2
Regulation number
866.3174
Medical specialty
Microbiology
Review panel
MI

FDA definition

Nucleic acid assay for detection of Hepatitis B Virus (HBV) DNA is an in vitro nucleic acid assay for detection and quantitation of HBV DNA in human serum or plasma. The assay can be used to measure HBV DNA levels at baseline and during treatment to aid in assessing response to treatment. The test results must be interpreted within the context of all relevant clinical and laboratory findings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 7 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from Aug 2, 2004 to Mar 4, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
MKT · Hepatitis Viral B Dna Detection07

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
Alinity m HBV Application Specification File (US and CE)Z-0883-2022 · MKTAbbott Molecular, Inc.RecallApr 6, 2022FDA classification date
Alinity m HBV AMP Kit (US and CE)Z-0884-2022 · MKTAbbott Molecular, Inc.RecallApr 6, 2022FDA classification date
cobas 6800/8800 system Hepatitis Viral B DNA Detection Product Usage: The cobas p512 pre-analytical system is a computer controlled fully automa…Z-0110-2017 · MKTRoche Diagnostics Operations, Inc.RecallOct 25, 2016FDA record creation date
COBAS AmpliPrep/COBAS TaqMan HBV v2.0 US-IVD; COBAS AmpliPrep/COBAS TaqMan HBV v2.0 CE-IVDZ-1459-2011 · MKTRoche Molecular Systems, Inc.RecallMar 1, 2011FDA classification date
Abbott RealTime HBV Assay, List 2N40, in vitro diagnostic; Abbott Molecular Inc., Des Plaines, IL 60018 USA The Abbott RealTime HBV is an in vitr…Z-1399-2011 · MKTAbbott MolecularRecallFeb 23, 2011FDA classification date
biphasic LIFEPAK 500 automated external defibrillators (AEDs) with software version 4.4 or lower; Part Nos. 3011790-XXXXXX, D3100790-XXXXXX, and …Z-1148-2007 · MKTMedtronic Emergency Response Systems, Inc.RecallAug 4, 2007FDA classification date
Zoll M Series Automated Defibrillator (AED)Z-1472-04 · MKTZoll Medical CorporationRecallSep 17, 2004FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗